Ning‐Fu Peng

Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study

Jian‐Hong Zhong, Ning‐Fu Peng, Xue‐Mei You et al. · Oncotarget · 2017 · 87 citations · Full text

Discordances in ER, PR and HER2 receptors between primary and recurrent/metastatic lesions and their impact on survival in breast cancer patients

Yufeng Yang, Ying‐Yang Liao, Mei Yang et al. · Medical Oncology · 2014 · 66 citations

Breast Oncology, Breast Cancer Patients, Medicine +7

Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancer

Yufeng Yang, Ying‐Yang Liao, Le‐Qun Li et al. · Pathology - Research and Practice · 2013 · 60 citations

Breast Oncology, Oncology, Her2 Receptors Status +9

Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment

Yufeng Yang, Ying‐Yang Liao, Xian-lian Liu et al. · Gynecologic Oncology · 2015 · 48 citations

Prognostic Factors, Tumoral Pathology, Gynecological Surgery +9

Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma

Shi‐Dong Lu, Yanyan Wang, Ning‐Fu Peng et al. · Medicine · 2016 · 47 citations · Full text

Surgical Oncology, High Nlr, Prognosis +19